WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-32.7%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

3Y CAGR
-32.7%/yr
Annual compound
Percentile
P71
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive growthAccelerating
PeriodValue
202526.01%
202418.44%
2023-28.48%
202285.20%
2021-10.94%
2020-9.85%
2019-11.92%
2018-8.45%
2017-32.64%
2016-17.97%